Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions — but this requires an injection. Now researchers report in the journal ACS Applied Materials & Interfaces a new way to deliver the treatment topically, without a needle.
The rear part of the eye is where conditions such as proliferative diabetic retinopathy and age-related macular degeneration develop. And they involve a substance called vascular endothelial growth factor, which stimulates the growth of blood vessels. Scientists have been trying to inhibit the growth factor using gene therapy, but delivering drugs to the back of the eye currently requires an injection. Not surprisingly, few patients opt for this type of treatment. Gang Wei and colleagues wanted to find a noninvasive approach.
The researchers developed a gene delivery system with a peptide called penetratin, which has shown good permeability in the eye, and a synthetic polymer called poly(amidoamine) that has previously been used in drug delivery. Testing on rats showed that the complex, when applied as an eye drop, rapidly moved from the eye’s surface to its rear inner lining. It remained in the retina for more than eight hours — enough time for a model gene to be expressed. The findings demonstrate the method’s potential for delivering gene therapy to treat several eye diseases, the researchers say.
The Latest on: Gene therapy in a droplet
via Google News
The Latest on: Gene therapy in a droplet
- Gene Therapy Stocks - A Buying Opportunityon October 6, 2020 at 3:48 pm
Some gene therapy stocks including ORTX, QURE and RGNX are trading considerably lower than in January of 2020.
- Gene Therapy’s Renaissanceon October 2, 2020 at 4:19 am
Gene therapy can work if you have identified the ... “Once you give IdeS, you see a sharp and immediate drop in circulating antibodies. They stay low for 3–4 days and then go up again ...
- Short Interest in Sinopharm Group Co. (OTCMKTS:TKBIF) Declines By 23.0%on October 1, 2020 at 10:40 pm
Sinopharm Group Co. (OTCMKTS:TKBIF) saw a large drop in short interest during the month of September. As of September 15th, there was short interest totalling 242,900 shares, a drop of 23.0% from the ...
- Chardan raises Solid Biosciences price target 250%on October 1, 2020 at 1:40 pm
Solid Biosciences (SLDB +81.0%) 'shines brightly' today after the FDA lifts hold on Duchenne study, evaluating its gene therapy candidate ... shares have witnessed a drop of ~80%.
- A COVID-19 vaccine may come without a needle, the latest vaccine to protect without jabbingon October 1, 2020 at 5:27 am
Vaccines are traditionally administered with a needle, but this isn't the only way. For example, certain vaccines can be delivered orally, as a drop on the tongue, or via a jet-like device.
- Impact Analysis of Covid-19on September 15, 2020 at 3:41 am
coupled with absolute quantification of gene expression and viral load. Moreover, technological advancements in the dPCR has driven manufacturers to launch droplet digital PCR (ddPCR ...
- COVID-19: Viral Vectors Market (2020-2024)- Roadmap for Recovery | Rising Prevalence of Chronic Diseases to Boost the Market Growth | Technavioon September 9, 2020 at 9:48 pm
While a few industries will register a drop in demand ... which is the leading segment in the market? The gene therapy is expected to be the leading segment based on application in the global ...
- The search beyond statinson August 19, 2020 at 1:42 pm
When the full patent for Pfizer's drug Lipitor (atorvastatin) expires in June 2011, the price could drop by 75% ... that inhibits expression of the gene encoding proprotein convertase subtilisin ...
- NextUp: This Company Is Using Gene Therapy to Target Rare Eye Diseaseson February 10, 2020 at 9:35 am
The new gene therapy is designed to treat NR2E3 mutation ... more than 90 percent of the drug contained in a conventional eye drop never reaches the eye tissues it intended to target.
- Early results boost hopes for historic gene editing attempton September 5, 2018 at 6:07 am
“I cannot absolutely say it’s a treatment effect” but the drop is “really encouraging ... Gene editing is intended as a more precise way to do gene therapy, to knock out a bad gene ...
via Bing News